Cancer Research Technology
Log in Register
Menu

Integrin AvB6 inhibiting Peptide

Info

Catalogue Number 151860
Relevance αvβ6 is a major new target for molecular-specific imaging and therapy of cancer. It is expressed only on epithelia and then usually only during processes of tissue remodelling; these include wound healing, chronic inflammation, and cancer. The αvβ6 inhibiting peptide could not only permit diagnostic imaging, but also to deliver anticancer therapy specifically to tumour cells while sparing local normal tissues.
Antigen/Gene or Protein Targets Integrin AvB6 inhibiting peptide
Research Area Cancer, Cell Structure and Motility

References: 2 entries

Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.

High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.

Europe PMC ID: 20629113


Add a reference

References: 2 entries

Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.

High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.

Europe PMC ID: 20629113


Add a reference

References: 2 entries

Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.

High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.


Add a reference


This reagent does not have any reviews at the moment.